STOK

NASDAQ HEALTHCARE

Stoke Therapeutics Inc

$29.03

-$0.31 (-1.06%)

Live quote

52w: $20.32 – $40.22

Loading chart…

P/E Ratio—

P/B Ratio5.42

EV/EBITDA—

Debt/Equity—

ROE-1.99%

ROIC—

Revenue Growth404.50%

Gross Margin—

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops new antisense oligonucleotide (ASO) drugs to treat the underlying causes of serious genetic diseases in the United States. The company is headquartered in Bedford, Massachusetts.

Own STOK? Track it here.

Create a free account to add STOK to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account